B cell activating anti-CD73 antibody for the immunotherapy of COVID-19

Despite the advent of numerous vaccines and the discovery of passive monoclonal antibodies for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), there remains an urgent need for definitive therapies for coronavirus disease-2019 (COVID-19) patients. Present global challenges in combatting the pandemic include – the emergence of viral variants; declining immunity following…

Researchers develop artificial inorganic cell-like structures to recreate functions of living cells

Researchers have developed artificial cell-like structures using inorganic matter that autonomously ingest, process, and push out material-; recreating an essential function of living cells. Their article, published in Nature, provides a blueprint for creating "cell mimics," with potential applications ranging from drug delivery to environmental science. A fundamental function of…

Existing drug may be effective in treating COVID-19

A new University of Chicago study has found that the drug masitinib may be effective in treating COVID-19. The drug, which has undergone several clinical trials for human conditions but has not yet received approval to treat humans, inhibited the replication of SARS-CoV-2 in human cell cultures and in a…